Nanologica AB Employee Directory
Biotechnology ResearchStockholm, Sweden11-50 Employees
Nanologica AB is a Swedish biotechnology company that focuses on nanoporous silica particles for purification by chromatography. Its production process allows precise control over particle shape, size, porosity and surface properties, enabling high-purity silica products used to purify peptide drugs such as insulin and GLP-1 analogues. These products aim to reduce costs and improve productivity for pharmaceutical manufacturers, potentially increasing access to affordable medicines for diabetes and obesity. The company is based in Södertälje in the Stockholm region and is listed on Nasdaq Stockholm Main Market. In early 2026 Nanologica expanded its asset base by acquiring Ardena's drug substance API site in Södertälje and the Syntagon manufacturing facility, reflecting a broader manufacturing footprint in Europe.